Defiance Nasdaq Junior Biotechnology ETF IBBJ
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 8.23M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 29.33
- 200-d avg
- 30.95
News
4 years ago etf.com
ETF Odds & Ends: Closures Accelerate
Plus, a large number of name and index changes occurred during the past two weeks.
5 years ago etf.com
ETF Odds & Ends: Launches Resurge
Plus, expense ratio changes and other ETF developments occurred during the week.
5 years ago etftrends.com
Biotech ETFs Benefit From Moderna Dual Booster Shot News
As the stock market attempts to reverse the recent pullback this month, Moderna shares climbed higher on Thursday after the company announced that it's creating a dual-purpose vaccine booster shot…
5 years ago zacks.com
Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News
The FDA granted full approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech that could accelerate inoculations in the United States.
5 years ago etftrends.com
Bet on Biotech Small Caps to Bounce Back
Large cap biotechnology have strengthened in recent months, but smaller counterparts are still waiting on their 2021 moment. When that happens, the Defiance Nasdaq Junior Biotechnology ETF (IBBJ)…
5 years ago investorplace.com
7 Stocks to Buy Now if You're Feeling Greedy While Others Are Fearful
Stock markets run on fear and greed in the short term. Here are seven stocks to buy that look like they have significant long-term upside.
5 years ago seekingalpha.com
Biotech Innovations Remain At Forefront
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively…
5 years ago seekingalpha.com
Moving Beyond COVID In Biopharma
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April…
5 years ago seekingalpha.com
Defiance ETFs: A Revolution In Thematic ETF Investing (Podcast Transcript)
Defiance ETFs: A Revolution In Thematic ETF Investing (Podcast Transcript)
5 years ago etftrends.com
Why Small Cap Biotech ETFs Are Still Brilliant Bets
Small cap stocks are retreating. So are biotechnology names.
5 years ago seekingalpha.com
Defiance ETFs: A Revolution In Thematic ETF Investing (Podcast)
Defiance ETFs: A Revolution In Thematic ETF Investing (Podcast)
5 years ago etftrends.com
Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021
After a lull in mergers and acquisitions activity, Big Pharma could begin to use its cash stores to buy out smaller targets, potentially fueling the momentum in biotechnology-related exchange traded…
5 years ago marketwatch.com
Biotech ETFs surge on vaccine rollout, Alexion-AstraZeneca tie-up
Biotech exchange-traded funds rallied Monday as the rollout of the coronavirus vaccine across America shed a bullish light on the industry. The First Trust NYSE Arca Biotechnology Index Fund jumped…
5 years ago benzinga.com
New Biotech ETF Quick To Strut Its Stuff
There are recipes for success for new exchange-traded funds. In an effort to attract assets and investors' attention, rookie ETFs can undercut established rivals on fees, offer exposure to a…
5 years ago etftrends.com
Young But Hungry: A New Defiance ETF is Defying Expectations
The Defiance Nasdaq Junior Biotechnology ETF (IBBJ) is just a few months in, but it's already asserting itself in the biotechnology exchange traded funds arena, one teeming with competition. IBBJ…
5 years ago businesswire.com
IBBJ ETF, the Junior Biotech ETF Outperforming Nasdaq Biotechnology Index
NEW YORK--(BUSINESS WIRE)---- $IBBJ #Biotech--About Defiance: Founded in 2018, Defiance ETFs is an exchange-traded funds (ETFs) sponsor and registered investment advisor, focused on thematic…
-
6 years ago benzinga.com
Defiance NextGen SPAC IPO ETF Launches: What Investors Need To Know
An ETF based on special purpose acquisition companies that trades on a U.S. exchange is now available to investors for the first time.